Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.

MLA

Krämer, Pauline, et al. “Endometrial Cancer Molecular Risk Stratification Is Equally Prognostic for Endometrioid Ovarian Carcinoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 26, no. 20, Oct. 2020, pp. 5400–10. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-20-1268.

APA

Krämer, P., Talhouk, A., Brett, M. A., Chiu, D. S., Cairns, E. S., Scheunhage, D. A., Hammond, R. F. L., Farnell, D., Nazeran, T. M., Grube, M., Xia, Z., Senz, J., Leung, S., Feil, L., Pasternak, J., Dixon, K., Hartkopf, A., Krämer, B., Brucker, S., … Anglesio, M. S. (2020). Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 26(20), 5400–5410. https://doi.org/10.1158/1078-0432.CCR-20-1268

Chicago

Krämer, Pauline, Aline Talhouk, Mary Anne Brett, Derek S Chiu, Evan S Cairns, Daniëlla A Scheunhage, Rory F L Hammond, et al. 2020. “Endometrial Cancer Molecular Risk Stratification Is Equally Prognostic for Endometrioid Ovarian Carcinoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26 (20): 5400–5410. doi:10.1158/1078-0432.CCR-20-1268.